The Canada Axillary Hyperhidrosis Treatment Market is entering a strong growth phase, supported by rising awareness, expanding treatment availability, and increasing acceptance of clinical care for ...

Millions of Americans struggle with excessive sweating that extends far beyond normal perspiration during exercise or hot weather. This condition, known medically as axillary hyperhidrosis when ...

- This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis - - The Company recently entered into a Clinical Trial ...

Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...

PRIMARY axillary hyperhidrosis is a condition affecting 4.8% of the USA population, characterised by excessive sweating in the underarms. This condition significantly impacts patients’ quality of life ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Sofpironium bromide in the treatment of primary axillary hyperhidrosis improves Hyperhidrosis Disease Severity Scale scores, reduces gravimetric weight of sweat, and improves Dermatology Life Quality ...